Stock Information
Exelixis Inc (EXEL)
Ticker Symbol: EXEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $12,600.43 mil
Piotroski score: 7
PE Ratio: 15.327
EPS (TTM): 3.0172
Revenue (TTM): $8.89 M
Dividend Yield: N/A%
ROE: 40.21%
Latest News
-
How The Exelixis (EXEL) Story Is Shifting As Wall Street Reworks Fair Value Targets
Fri, May 29, 2026 1:11 PM
-
Dow Jones Futures Rise As Dell, NetApp Surge On Earnings; Oil Falls On U.S.-Iran Deal Hopes
Fri, May 29, 2026 11:56 AM
-
How Investors Are Reacting To Exelixis (EXEL) Expanding Beyond CABOMETYX With New Colorectal Cancer Trials
Fri, May 29, 2026 5:03 AM
-
Dow Jones Futures: Stock Market Hits Highs On U.S.-Iran Deal; Dell Surges On Earnings
Thu, May 28, 2026 9:49 PM
-
If Decades of History Tell Us Anything, This Biotech Near $50 Is Primed to Skyrocket
Thu, May 28, 2026 2:23 PM
-
Exelixis, Inc. (EXEL) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript
Thu, May 28, 2026 3:00 AM
-
Exelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in June
Wed, May 27, 2026 8:05 PM
-
Exelixis: Financial Performance Improves Faster Than Market Expectations
Sat, May 23, 2026 5:26 PM
-
Exelixis Eyes CABO Growth as Zanzalintinib Readouts and Potential CRC Launch Near
Sat, May 23, 2026 9:04 AM
-
Exelixis (EXEL): 12 Best Low Priced Growth Stocks to Invest In Now
Fri, May 22, 2026 7:28 PM
Key Financials
Financial data not available